No Data
No Data
Institutional Investors Are Rezolute, Inc.'s (NASDAQ:RZLT) Biggest Bettors and Were Rewarded After Last Week's US$53m Market Cap Gain
Key Insights Significantly high institutional ownership implies Rezolute's stock price is sensitive to their trading actions 55% of the business is held by the top 4 shareholders Insiders have be
Rezolute to Participate in the Jefferies Global Healthcare Conference
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) ("Rezolute" or the "Company"), a clinical-stage biopharmaceutical company committed to developing novel, transfor
Rezolute(RZLT.US) Officer Buys US$20,137.8 in Common Stock
$Rezolute(RZLT.US)$ Officer ROBERTS BRIAN KENNETH purchased 7,500 shares of common stock on May 23, 2024 at an average price of $2.685 for a total value of $20,137.8.Source: Announcement What is state
Rezolute(RZLT.US) Officer Buys US$9,667.96 in Common Stock
$Rezolute(RZLT.US)$ Officer Evans Daron purchased 3,000 shares of common stock on May 23, 24, 2024 at an average price of $3.22 for a total value of $9,667.96.Source: Announcement What is statement of
Maxim Group Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $8
Maxim Group analyst Jason McCarthy maintains $Rezolute(RZLT.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 31.8% and a total
JMP Securities Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $7
JMP Securities analyst Jason Butler maintains $Rezolute(RZLT.US)$ with a buy rating, and maintains the target price at $7.According to TipRanks data, the analyst has a success rate of 38.7% and a tota
No Data